Long‐Bin Jeng

1.5k total citations
61 papers, 1.1k citations indexed

About

Long‐Bin Jeng is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Long‐Bin Jeng has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 20 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Long‐Bin Jeng's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Long‐Bin Jeng is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Hepatitis B Virus Studies (8 papers) and Liver Disease Diagnosis and Treatment (8 papers). Long‐Bin Jeng collaborates with scholars based in Taiwan, Saudi Arabia and United States. Long‐Bin Jeng's co-authors include Wei‐Chen Lee, Chun‐Nan Yeh, Chiao‐Fang Teng, Miin‐Fu Chen, Yi-Yin Jan, Jui‐Hsiang Lin, Kuang‐Chi Lai, Chuen Hsueh, Jir S. Tsai and Wen‐Ling Chan and has published in prestigious journals such as JAMA, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Long‐Bin Jeng

58 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Long‐Bin Jeng Taiwan 20 423 390 295 205 181 61 1.1k
Vincent Zimmer Germany 19 436 1.0× 208 0.5× 364 1.2× 209 1.0× 187 1.0× 164 1.1k
Justin Parekh United States 17 427 1.0× 351 0.9× 229 0.8× 173 0.8× 88 0.5× 36 965
Saiho Ko Japan 19 561 1.3× 472 1.2× 248 0.8× 215 1.0× 140 0.8× 68 1.3k
Phaik‐Leng Cheah Malaysia 20 266 0.6× 121 0.3× 359 1.2× 211 1.0× 178 1.0× 92 1.1k
Isabella Reccia United Kingdom 18 503 1.2× 138 0.4× 207 0.7× 147 0.7× 146 0.8× 48 1.1k
Tsu‐Yi Chao Taiwan 18 217 0.5× 309 0.8× 375 1.3× 337 1.6× 170 0.9× 61 1.1k
Jianyong Lei China 24 612 1.4× 385 1.0× 235 0.8× 242 1.2× 122 0.7× 88 1.6k
Izumi Muraoka Japan 11 631 1.5× 496 1.3× 300 1.0× 283 1.4× 315 1.7× 35 1.4k
Tsung‐Han Wu Taiwan 22 542 1.3× 701 1.8× 345 1.2× 271 1.3× 167 0.9× 111 1.3k
Sang Jun Suh South Korea 17 246 0.6× 646 1.7× 596 2.0× 102 0.5× 103 0.6× 50 1.1k

Countries citing papers authored by Long‐Bin Jeng

Since Specialization
Citations

This map shows the geographic impact of Long‐Bin Jeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Long‐Bin Jeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Long‐Bin Jeng more than expected).

Fields of papers citing papers by Long‐Bin Jeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Long‐Bin Jeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Long‐Bin Jeng. The network helps show where Long‐Bin Jeng may publish in the future.

Co-authorship network of co-authors of Long‐Bin Jeng

This figure shows the co-authorship network connecting the top 25 collaborators of Long‐Bin Jeng. A scholar is included among the top collaborators of Long‐Bin Jeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Long‐Bin Jeng. Long‐Bin Jeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Pei-Chun, Yingchun Yu, Chun-Chieh Yeh, et al.. (2025). Ether-lipids accumulation promotes hepatocellular carcinoma progression linked to PPARα deficiency. Journal of Biomedical Science. 32(1). 89–89.
2.
Lee, Wei, et al.. (2023). Novel Programmed Death Ligand 1-AKT-engineered Mesenchymal Stem Cells Promote Neuroplasticity to Target Stroke Therapy. Molecular Neurobiology. 61(7). 3819–3835. 5 indexed citations
3.
Jeng, Long‐Bin, John Wang, & Chiao‐Fang Teng. (2023). Predictive Biomarkers of Immune Checkpoint Inhibitor-Based Mono- and Combination Therapies for Hepatocellular Carcinoma. Journal of Cancer. 15(2). 484–493. 2 indexed citations
4.
Hsiao, Lien‐Cheng, Mei‐Yao Wu, Yunfang Chen, et al.. (2023). PD-L1 and AKT Overexpressing Adipose-Derived Mesenchymal Stem Cells Enhance Myocardial Protection by Upregulating CD25+ T Cells in Acute Myocardial Infarction Rat Model. International Journal of Molecular Sciences. 25(1). 134–134. 5 indexed citations
5.
Lin, Hung‐Jen, et al.. (2023). Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 15(1). 19–35. 4 indexed citations
6.
Chen, I−Ru, Guei‐Jane Wang, Po‐Ren Hsueh, et al.. (2023). Immune responses and safety of COVID-19 vaccination in atypical hemolytic uremic syndrome patients in Taiwan. Vaccine. 41(41). 5940–5945. 1 indexed citations
7.
Chang, Kuan‐Cheng, Yen‐Nien Lin, Mao‐Wang Ho, et al.. (2022). Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO2/FiO2 in severe COVID-19 pneumonia. Frontiers in Medicine. 9. 1001979–1001979. 3 indexed citations
8.
Lin, Mei‐Chen, et al.. (2021). Evaluation of delayed bleeding risks associated with partial hepatectomy: A nationwide population-based propensity score matching study. International Journal of Surgery. 90. 105980–105980.
9.
Yang, Horng-Ren, et al.. (2018). Laparoscopic Liver Resection: Experience of 436 Cases in One Center. Journal of Gastrointestinal Surgery. 23(10). 1949–1956. 13 indexed citations
10.
Tsai, Ming‐Shian, Yu-Chiao Wang, Y. H. Kao, Long‐Bin Jeng, & Chia‐Hung Kao. (2015). Preexisting Diabetes and Risks of Morbidity and Mortality After Gastrectomy for Gastric Cancer. Medicine. 94(37). e1467–e1467. 10 indexed citations
11.
Sun, Li‐Min, Yung‐Ting Kuo, Long‐Bin Jeng, et al.. (2015). Hypertension and Subsequent Genitourinary and Gynecologic Cancers Risk. Medicine. 94(16). e753–e753. 23 indexed citations
12.
Hou, Pei‐Chi, Kuan‐Der Lee, Pei‐Yi Chu, et al.. (2011). Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells. Cancer Research. 71(13). 4653–4663. 79 indexed citations
13.
Jeng, Long‐Bin, T. M. Lin, Jyh‐Ping Chen, et al.. (2008). Characterization and osteogenic effects of mesenchymal stem cells on microbeads composed of hydroxyapatite nanoparticles/reconstituted collagen. Journal of Biomedical Materials Research Part A. 91A(3). 886–893. 10 indexed citations
14.
Lai, Kuang‐Chi, Meng‐Chih Lee, Po-Hui Wang, et al.. (2007). Comparison of Escherichia coli and Klebsiella pneumoniae Liver Abscesses. The American Journal of the Medical Sciences. 334(2). 97–105. 57 indexed citations
15.
Hsu, Wu-Huei, et al.. (2006). 2049. Ultrasound in Medicine & Biology. 32(5). P94–P94. 1 indexed citations
16.
Yeh, Chun‐Nan, et al.. (2002). Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: Univariate and multivariate analysis. Journal of Surgical Oncology. 81(4). 195–202. 165 indexed citations
17.
Jeng, Long‐Bin, et al.. (2001). CASE REPORT: Aspirin-Related Hepatotoxicity in a Child After Liver Transplant. Digestive Diseases and Sciences. 46(3). 486–488. 4 indexed citations
18.
Jan, Yi-Yin, et al.. (2000). Impact of Concomitant Hepatolithiasis on Patients with Peripheral Cholangiocarcinoma. Digestive Diseases and Sciences. 45(2). 312–316. 46 indexed citations
19.
Jeng, Long‐Bin, et al.. (2000). Dendritic cell progenitors prolong allograft survival through T-Helper 2 deviation of the Th1/Th2 Paradigm. Transplantation Proceedings. 32(7). 2076–2077. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincent Zimmer Breakdown of academic impact, for papers by Justin Parekh Breakdown of academic impact, for papers by Saiho Ko Breakdown of academic impact, for papers by Phaik‐Leng Cheah Breakdown of academic impact, for papers by Isabella Reccia Breakdown of academic impact, for papers by Tsu‐Yi Chao Breakdown of academic impact, for papers by Jianyong Lei Breakdown of academic impact, for papers by Izumi Muraoka Breakdown of academic impact, for papers by Tsung‐Han Wu Breakdown of academic impact, for papers by Sang Jun Suh
Rankless by CCL
2026